Table of Contents
Executive Summary — 5
SWOT
Analysis — 6
Ukraine Pharmaceutical And Healthcare
Industry SWOT — 6
Ukraine Political
SWOT — 7
Ukraine Economic SWOT — 8
Ukraine Business Environment SWOT — 9
Pharmaceutical
Business Environment Rating — 10
Table: Central And
Eastern Europe Pharmaceutical Business Environment
Rankings — 10
Limits To Potential
Returns — 11
Risk to Realisation Of
Returns — 11
Ukraine – Market
Summary — 13
Regulatory Regime — 16
Intellectual Property Issues — 21
Pricing and
Reimbursement Issues — 23
Other Market Entry
Barriers — 28
Industry
Developments — 30
Medical Devices — 33
Industry Forecast Scenario — 34
Overall Market
Forecast — 34
Table: Ukraine’s Drug Market
Indicators — 36
Key Growth Factors –
Industry — 37
Table: Ukraine Health Expenditure, 2004
– 2013 — 39
Key Growth Factors –
Macroeconomic — 40
Table:-Ukraine - Economic Activity,
2005-2013 — 45
Prescription Market
Forecast — 46
Table: Prescription Drug Market Indicators,
2006-2013 (US$mn unless otherwise stated) — 47
Generics
Market Forecast — 48
Table: Generic And Patented Drugs
Market Indicators — 49
OTC Market
Forecast — 51
Table: OTC Market Indicators (US$mn unless
otherwise stated) — 52
Export/Import
Forecasts — 53
Table: Import/Export Forecasts
(US$mn) — 54
Other Healthcare Data
Forecasts — 54
Table: Healthcare Data,
2005-2013 — 54
Competitive
Landscape — 55
Manufacturing
Sector — 55
Wholesale — 62
Retail — 63
Table: Pharmacies And Pharmacy Market Ratios,
2004-2009 — 65
Company Monitors — 66
Arterium — 66
Gedeon Richter — 69
Krka — 72
Lek (Novartis/Sandoz) — 74
Country Snapshot: Ukraine Demographic Data — 76
Section 1:
Population — 76
Table: Demographic Indicators,
2005-2030 — 76
Table: Rural/Urban Breakdown,
2005-2030 — 77
Section 2: Education And
Healthcare — 77
Table: Education,
2002-2005 — 77
Table: Vital Statistics,
2005-2030 — 77
Section 3: Labour Market And Spending
Power — 78
Table: Employment Indicators,
2001-2006 — 78
Table: Consumer Expenditure, 2000-2012
(US$) — 78
Table: Average Annual Wages,
2000-2012 — 79
BMI Forecast
Modelling — 80
How We Generate Our Pharmaceutical Industry
Forecasts — 80
Pharmaceutical Business Environment Ratings
Methodology — 81
Ratings Overview — 81
Table: Pharmaceutical Business Environment Indicators — 81
Weighting — 83
Table: Weighting Of
Components — 83
Sources — 83
| 
View Cart
